Meet Our Ottawa Chapter Team!
The Ottawa S2BN Chapter partners with regional stakeholders to organize career development and networking events for STEM and Health/Life Sciences graduate trainees. Our aim is to support the growth of Ontario's Health and Life Sciences sector by preparing highly qualified personnel for a career path outside of academia.
Joey Sheff, PhD
Human Health Therapeutics,
National Research Council Canada
Joey Sheff is a Research Officer in Human Health Therapeutics at the National Research Council Canada. There, he is a bilingual expert in structural proteomics. where his main role is to build, adapt, and innovate a structural mass spectrometry tool box for the study of emerging biotherapeutic. He also holds an appointment as adjunct professor in the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa.
Event Support Associate
Univerisity of Ottawa
I am Fatemeh Rezaei, a PhD student majoring in Biochemistry at the University of Ottawa. As part of Dr. Jyh-Yeuan (Eric) Lee's lab, I perform structural biology research to determine the structure of cholesterol transporters.
Event Support Associate;
PhD Candidate, Health Canada
Alicia Zhang received her Bachelor of Science from the University of British Columbia in 2016, with a Major in Biochemistry and Minor in Microbiology. After graduation she worked in the Research & Development department at STEMCELL Technologies Inc. for 3 years, developing and launching products to support stem cell research. Currently Alicia is pursuing a PhD in Immunology in the vaccine laboratory at Health Canada, focusing on vaccines against highly contagious respiratory viruses, including influenza and SARS-CoV-2.
Emily Freeman, PhD
Event Support Associate
CHEO Research Institute
Emily earned her Bachelor of Science Honours in Biology (2016) from Brock University and a Master of Science in cellular and molecular medicine (2019) from the University of Ottawa. Here, she studied the crosstalk between cell signaling pathways and how they go wrong in Duchenne muscular dystrophy. She is currently finishing her PhD in cellular and molecular medicine at the University of Ottawa. During her PhD, she discovered that the small molecule channel Pannexin 1 holds sex-dependant roles in muscle and is now focused on discovering new Pannexin 1 targeted therapeutics for Duchenne muscular dystrophy. In addition to her work with muscle, she works with an up and coming biotech company CureO-V where she develops and optimizes mid-scale viral production and purification methods for oncolytic vaccine candidates.
Event Support Associate
George obtained his Bachelor of Science degree in Biochemistry and Biotechnology with a minor in chemistry, from Carleton university in 2022. He is currently pursuing a Master’s degree in biology at Carleton University with a specialization in Biochemistry, supervised by Dr. Bill Willmore. During his masters, George synthesizes peptide sequences using standard Fmoc- chemistry (solid phase synthesis), where the peptides have a fluorescent tag (FITC) and contain moieties responsible for targeting cell surface receptors and can penetrate into the cytoplasm of the cell. These peptides are characterized using various methods (LCMS, CD spectroscopy, Absorbance and emission profiles to name a few) then complexed with small interfering RNA (siRNA) to create nanostructures that can downregulate specific protein chaperones within the cells. The peptides can be analyzed within live cell cultures using MCF7, MCF10, and MDA-MB-231, and analyzed through confocal microscopy, flowcytometry, and PCR.
Virtual Territory Manager - Diabetes at Inizio Engage
Mihir Bhatt is a Medical School graduate from the Royal College of Surgeons in Ireland and has completed a Graduate Diploma in Business program from the Smith School of Business. His true passion lies in the utilization of his business and medical background in order to make an impact in the healthcare industry. He has quite recently made a leap towards his end goal of being involved in medical education by accepting a position with Ashfield Healthcare where he will be an Internal Representative in the pharmaceutical space.
MSc Neuroscience, University of Ottawa
Anjali Patel has recently completed a MSc. in Neuroscience at the University of Ottawa. Her work in the lab of Dr. Maxime Rousseaux utilized cell and mouse models to study the cellular and molecular mechanisms underlying neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and Parkinson’s. In addition to conducting research in the lab, Anjali completed an industry internship with the Ximbio Ximbassador Program where she worked to identify and help commercialize life science tools and reagents invented at the University of Ottawa. Anjali’s interests lie in biotech and drug discovery, and she is passionate about science communication and outreach.